Cargando…
Human Vaccines & Immunotherapeutics: News
Long-term effectiveness shown for Merck’s chickenpox vaccine Again—no link between vaccines and autism Experimental ovarian cancer vaccine successful in phase 1 Sinovac’s HFMD vaccine meets phase 3 study goal A vaccine for long-suffering cat allergy patients Vaccines are key to breaking infectious d...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899159/ http://dx.doi.org/10.4161/hv.25213 |
| _version_ | 1782300527718039552 |
|---|---|
| author | Riedmann, Eva M. |
| author_facet | Riedmann, Eva M. |
| author_sort | Riedmann, Eva M. |
| collection | PubMed |
| description | Long-term effectiveness shown for Merck’s chickenpox vaccine Again—no link between vaccines and autism Experimental ovarian cancer vaccine successful in phase 1 Sinovac’s HFMD vaccine meets phase 3 study goal A vaccine for long-suffering cat allergy patients Vaccines are key to breaking infectious disease-malnutrition cycle Cancer vaccine failures due to the adjuvant IFA? Novartis’ typhoid vaccine make good progress |
| format | Online Article Text |
| id | pubmed-3899159 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Landes Bioscience |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-38991592014-02-03 Human Vaccines & Immunotherapeutics: News Riedmann, Eva M. Hum Vaccin Immunother News, Policy & Profiles Long-term effectiveness shown for Merck’s chickenpox vaccine Again—no link between vaccines and autism Experimental ovarian cancer vaccine successful in phase 1 Sinovac’s HFMD vaccine meets phase 3 study goal A vaccine for long-suffering cat allergy patients Vaccines are key to breaking infectious disease-malnutrition cycle Cancer vaccine failures due to the adjuvant IFA? Novartis’ typhoid vaccine make good progress Landes Bioscience 2013-05-01 2013-08-21 /pmc/articles/PMC3899159/ http://dx.doi.org/10.4161/hv.25213 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
| spellingShingle | News, Policy & Profiles Riedmann, Eva M. Human Vaccines & Immunotherapeutics: News |
| title | Human Vaccines & Immunotherapeutics: News |
| title_full | Human Vaccines & Immunotherapeutics: News |
| title_fullStr | Human Vaccines & Immunotherapeutics: News |
| title_full_unstemmed | Human Vaccines & Immunotherapeutics: News |
| title_short | Human Vaccines & Immunotherapeutics: News |
| title_sort | human vaccines & immunotherapeutics: news |
| topic | News, Policy & Profiles |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899159/ http://dx.doi.org/10.4161/hv.25213 |
| work_keys_str_mv | AT riedmannevam humanvaccinesimmunotherapeuticsnews |